ACQUIREDT+7
Grace Therapeutics Inc · NASDAQ
+1,694 sh · $3.5K
Filed 5 Oct 2026SEC Form 4view source
- ACQUIREDT+7
Grace Therapeutics Inc · NASDAQ
+20,000 sh · $41.4K
Filed 5 Oct 2026SEC Form 4view source - ACQUIREDT+7
Grace Therapeutics Inc · NASDAQ
+38,796 sh · $79.0K
Filed 5 Oct 2026SEC Form 4view source - ACQUIREDT+30
Alpha Cognition Inc · NASDAQ
+19,050 sh · $165.6K
Filed 2 Oct 2026SEC Form 4view source - ACQUIREDT+30
Grace Therapeutics Inc · NASDAQ
+7,849 sh · $16.4K
Filed 1 Oct 2026SEC Form 4view source - ACQUIREDT+30
Grace Therapeutics Inc · NASDAQ
+5,318 sh · $11.2K
Filed 1 Oct 2026SEC Form 4view source - ACQUIREDT+30
Grace Therapeutics Inc · NASDAQ
+9,771 sh · $20.5K
Filed 1 Oct 2026SEC Form 4view source - ACQUIREDT+30
Alpha Cognition Inc · NASDAQ
+18,337 sh · $157.1K
Filed 28 Sept 2026SEC Form 4view source - ACQUIREDT+30
Alpha Cognition Inc · NASDAQ
+13,426 sh · $113.7K
Filed 28 Sept 2026SEC Form 4view source - ACQUIREDT+30
Alpha Cognition Inc · NASDAQ
+3,375 sh · $28.8K
Filed 16 Sept 2026SEC Form 4view source - ACQUIREDT+30
Alpha Cognition Inc · NASDAQ
+40,373 sh · $351.1K
Filed 16 Sept 2026SEC Form 4view source - ACQUIREDT+30
Alpha Cognition Inc · NASDAQ
+27,141 sh · $228.0K
Filed 16 Sept 2026SEC Form 4view source - ACQUIREDT+30
Alpha Cognition Inc · NASDAQ
+53,029 sh · $454.6K
Filed 16 Sept 2026SEC Form 4view source - ACQUIREDStale
Grace Therapeutics Inc · NASDAQ
+5,836 sh · $12.2K
Filed 10 Sept 2026SEC Form 4view source - ACQUIREDStale
Grace Therapeutics Inc · NASDAQ
+9,393 sh · $19.7K
Filed 10 Sept 2026SEC Form 4view source - ACQUIREDStale
Grace Therapeutics Inc · NASDAQ
+11,608 sh · $24.2K
Filed 19 Aug 2026SEC Form 4view source